AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
INSULIN DETEMIR
7 registrations across 6 African markets— 6 active
Markets with INSULIN DETEMIR
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| LEVEMIR FLEXPEN INJECTABLE; INJECTION | 🇿🇼Zimbabwe | NOVO NORDISK KENYA LIMITED | active | Jun 2031 |
| LEVEMIR_FLEXPEN 100U/ml INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| LEVEMIR | 🇿🇦South Africa | Novo Nordisk (Pty) Ltd û (Rivonia) | active | Jan 1900 |
| Insulatard vial Solution for injection | 🇹🇿Tanzania | Novo Nordisk A/S | active | — |
| Levemir FlexPen 100 Units/mL Solution for Injection in Pre-filled Pen Solution for injection | 🇳🇬Nigeria | — | active | — |
| INSULIN DETEMIR PARENTERAL
ORDINARY PRE-
FILLED PENS | 🇺🇬Uganda | NOVO NORDISK PHARMA GULF FZ- LC | active | — |
| INSULIN DETEMIR PARENTERAL
ORDINARY PRE-
FILLED PENS | 🇺🇬Uganda | NOVO NORDISK PHARMA GULF FZ- LC | active | — |
INSULIN DETEMIR in Africa — Regulatory Overview
INSULIN DETEMIR is registered across 6 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Nigeria, Tanzania and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 6 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.